[go: up one dir, main page]

EP0409869A1 - Fragments promoteurs de l'adn du ble - Google Patents

Fragments promoteurs de l'adn du ble

Info

Publication number
EP0409869A1
EP0409869A1 EP89904391A EP89904391A EP0409869A1 EP 0409869 A1 EP0409869 A1 EP 0409869A1 EP 89904391 A EP89904391 A EP 89904391A EP 89904391 A EP89904391 A EP 89904391A EP 0409869 A1 EP0409869 A1 EP 0409869A1
Authority
EP
European Patent Office
Prior art keywords
aba
plant
nucleic acid
promoter fragment
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP89904391A
Other languages
German (de)
English (en)
Inventor
James Cooper Litts
William Richard Marcotte, Jr.
Ralph Stephen Quatrano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon State University
Oregon State
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Oregon State University
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co, Oregon State University, Oregon State filed Critical EI Du Pont de Nemours and Co
Publication of EP0409869A1 publication Critical patent/EP0409869A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8234—Seed-specific, e.g. embryo, endosperm
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237—Externally regulated expression systems
    • C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance

Definitions

  • This invention relates to the preparation of nucleic acid promoter fragments homologous to the Em gene of wheat which are responsive to compounds possessing abscisic acid-like activity, and their incorporation into recombinant DNA constructs to bring the expression of nucleic acid sequences for selected gene products operably linked to the promoter fragments under external control in protoplasts and plants.
  • the external control of the expression of selected gene products in plants through the application of chemical substances can provide important agronomic and foodstuff benefits.
  • the ability to externally control the expression of introduced genes in transgenic plants could be used to (1) prolong or extend the accumulation of desirable nutritional food reserve in seeds, roots, or tubers, (2) produce and accumulate products in plant tissues that are convenient for harvest and isolation, and (3) initiate expression of a toxin at the site of pathogen attack, possibly avoiding contamination of the ultimate food product with the toxin.
  • stage or tissue specific promoters While technology exists to transform plants with the genes for selected products, their expression is either continuous throughout the life cycle (controlled by a constitutive promoter), or is regulated by the developmentally timed program of maturation inherent in each organ/tissue/cell (stage or tissue specific promoters). Continuous expression precludes production at particular stages, in specific tissues or in response to environmentally unpredictable events. Such expression could place a major penalty on yield, due to greatly increased energy demands accompanying prolonged synthesis of the product. Tissue or stage specific expression, although valuable for the temporal and spatial accumulation of products, is under the variable timing of the developmental program of the plant. Precise developmental control of gene expression would necessitate the isolation of a multitude of stage and tissue specific promoters in all crop plants of interest.
  • one chemical/promoter combination can be interactive at any stage or in any tissue available to the chemical, throughout the life cycle of any one of a large number of transformable plants, to control any desired gene product.
  • Certain genes can be induced by environmental factors such as light, heat shock and anaerobiosis.
  • the promoters of these inducible genes from plants have been extensively analyzed (c.f., Kuhlemeier et al., Ann. Rev. PI. Physiol., 38:221-257 (1987)).
  • the inducers of these genes i.e., light, temperature and O 2 levels
  • ABA phytohormone abscisic acid
  • Applicant's invention lies in the isolation of promoter fragments, their use in constructs to transform protoplasts and plants, and in achieving the external control of plant gene expression.
  • Adhl maize alcohol dehydrogenase
  • Adhl inducible promoter from a monocot maize gene
  • Their results demonstrated the normal regulation of an inducible promoter from a monocot maize gene (i.e., Adhl) when electroporated into protoplasts derived from a homologous cell culture system. They showed that just the Adhl , promoter fragment, without the. coding and 3' regions of the Adhl gene, is sufficient for anaerobic induction of the CAT gene.
  • the fragment of DNA consisting of 247 bp adjacent and 5' to the transcription start site of the structural gene for Adhl, was sufficient to put the expression of the CAT gene under anaerobic control. Therefore, anaerobic control by the 247 bp fragment of DNA was maintained even when the octopine synthase and CaMV 35S promoters, which are constitutive promoters, were present.
  • the region of the Adhl promoter responsible for anaerobic induction demonstrated in transient assays by Howard et al., Lee et al., and Walker et al. were similar to the region showing anaerobic induction in stably transformed plants by Ellis et al.
  • Patents have been issued to animal and microbial systems in which selected gene sequences have been induced by chemicals in the environment that interact with certain regulatory sequences.
  • U.S. Patent 4,579,821 issued to Palmiter and Brinster, discloses the isolation of promoter/regulator sequences of the mouse metallothionein-I gene and its use to control the expression of selected DNA sequences operably linked to the promoter by exposure to heavy metal ions or steroid hormones. The expression of thymidine kinase fused to the metallothionein-I promoter was obtained in differentiated cells of adult mice upon administration of cadium or dexamethasone.
  • Patent 4,703,005 issued to Nakata and Shinagaua, discloses the isolation of a gene for phosphate-binding protein (phoS) to which was fused a foreign gene 3' to phoS.
  • the foreign gene is controlled by phosphate in the culture medium.
  • Em gene of wheat is an inducible gene, responsive to ABA, which is accumulated and implicated in the physiological events of embryo maturation and drought stress protection.
  • ABA ABA-like ABA
  • novel promoter fragments derived from the Em gene which can be used to achieve external control of selected genes, and it is believed that promoter regions from other plant genes homologous to the Em structural gene of wheat will function similarly.
  • one preferred aspect of the present invention is a nucleic acid promoter fragment comprising a nucleotide sequence from the 5' flanking promoter region of a plant gene homologous to the Em structural gene of wheat, said promoter fragment being responsive in transformed plant cells to compounds possessing ABA-like activity such that the expression of DNA sequences for selected gene products operably linked on the 3' side of said promoter fragment can be controlled with the proviso that such promoter fragments are not responsive to phaseic acid.
  • nucleic acid promoter fragment comprising a nucleotide sequence from the 5' flanking promoter region of the Em structural gene of wheat, said promoter fragment being responsive in plant cells to compounds possessing ABA-like activity such that the expression of nucleic acid sequences for selected gene products operably linked on the 3' side of said promoter fragment can be controlled.
  • the invention is thus broadly applicable for securing control of many genetic processes, ranging from the alteration of existing regulation of endogenous genes in plant cells, to securing selective regulation of expression of selected foreign genes stably incorporated in plant cells.
  • Preferred compounds possessing ABA-like activity include ABA, Compound C, Compound D, Compound E, and Compound F (as defined herein).
  • preferred promoter fragments for use in practice of the invention are derived from the Em gene of wheat, specifically, an 1850 bp nucleic acid promoter fragment. More preferred is a 640 bp nucleic acid promoter fragment. Most preferred, by virtue of ease of use in constructs and effective use in plants, are a 254 bp and a 50 bp nucleic acid promoter fragment derived from the regulatory DNA sequence controlling the expression of the Em structural gene of wheat. Such promoter fragments are also defined by their nucleic acid sequence.
  • Another aspect of this invention involves a recombinant DNA construct capable of modifying the properties of a protoplast comprising a nucleic acid promoter fragment of the Em gene of wheat, and a DNA sequence for a selected gene product operably linked to said promotor fragment such that upon exposure to a compound possessing ABA-like activity said DNA sequence for a selected gene product is expressed.
  • Another embodiment involves a recombinant DNA construct capable of transforming a plant cell comprising a nucleic acid promoter fragment of the Em gene of wheat, a DNA sequence for a selected gene product operably linked to said promoter fragment, and a suitable regulatory sequence such that upon exposure to a compound possessing ABA-like activity said DNA sequence for a selected gene product is expressed.
  • These constructs may be incorporated into DNA plasmid vectors to provide useful tools in the transformation of a wide variety of plant cells, plant tissues and plants.
  • Yet another aspect of this invention involves a transient assay method to evaluate the likelihood of expression of a selected gene product in a stably transformed plant comprising the steps of (a) preparing protoplasts from rice, (b) transferring to said protoplasts a recombinant DNA construct incorporating a nucleic acid promoter fragment of the Em gene of wheat and an operably linked DNA sequence for a selected gene product, (c) incubating said protoplasts containing said construct with a compound possessing ABA-like activity, and (d) measuring the amount of said selected gene product expressed in response to said compounds.
  • Another process embodiment of the invention involves a method for controlling the expression of a selected gene product in a plant comprising the steps of (a) transforming said plant with a recombinant DNA construct incorporating a nucleic acid promoter fragment of the Em gene of wheat and an operably linked DNA sequence for a selected gene product, and a suitable regulatory sequence, (b) exposing said plant to a compound possessing ABA-like activity, and (c) causing said plant to express said selected gene product at a desired time.
  • a final aspect of the invention involves a nucleic acid fragment for controlling over-production of a selected gene product in plants in response to drought conditions comprising. a nucleic acid promoter fragment responsive to ABA inserted into the CaMV 35S promoter sequence.
  • a nucleic acid promoter fragment responsive to ABA inserted into the CaMV 35S promoter sequence.
  • Characterization of the regulation of the promoter fragment of the Em gene of wheat has been carried out utilizing rice protoplasts. This system is preferred based upon the rapid response of transformed rice protoplasts to compounds possessing ABA-like activity, the ability to regenerate transgenic rice plants from protoplasts and to predict the response in a stably transformed plant. Further, to easily and rapidly measure the response of a compound possessing ABA-like activity, a reporter gene is operably linked to the promoter fragment.
  • the reporter gene chosen is that for the enzyme ⁇ -glucuronidase (GUS) for several reasons; no background enzyme activity is detected in plant cells, an extremely sensitive and quantitative fluorometric assay is available, and the enzyme activity is very stable.
  • GUS ⁇ -glucuronidase
  • Figure 1 is a physical map of plasmid pBM108 as derived from plasmids pRAJ260 and pDH51.
  • Figure 2 is a physical map of plasmid pBM109 as derived from plasmids pBM108 and pUC18.
  • Figure 3 is the nucleotide sequence of the Em gene 5' flanking region from -1328 to +6 from the translational start codon.
  • the translational start codon, ATG is underlined.
  • Figure 4 is a physical map of plasmid pBM113 as • derived from plasmids pBM109 and pEAS41.8.
  • Figure 5 is a physical map of plasmids pBM113Kp and pBM311 as derived from plasmids pBM109 and pBM113,
  • Figure 6 is a physical map of plasmids PBM113 ⁇ 220.10, pBM113 ⁇ 220.9 and pBM113 ⁇ 240.13 as derived from plasmid pBM113.
  • Figure 7 is a physical plasmid map of plasmid pBM117 as derived from plasmids pDH51 and pBM109.
  • Figure 8 is a physical map of plasmid pBM119.as derived from plasmids pUC18 and pRAJ275.
  • Figure 9 is a physical map of plasmids pCS102 and pBM120 as derived from plasmids pDH51 and pBM119.
  • Figure 10 is a physical map of plasmid series pBM165 and plasmid series pBM167 as derived from plasmids pDH51, a 56 bp oligonucleotide, and plasmid pBM120.
  • Figure 11 is a physical map of plasmid pBM152 as derived from plasmids pDH51 and pBM120.
  • Figure 12 is a physical map of plasmid pBM1170 as derived from plasmids pBM117 and pBI101.1.
  • Figure 13 is a physical map of plasmid ⁇ BM1130 as derived from plasmids pBM113Kp and pBI101.1.
  • Figure 14 is a physical map of plasmid pBM3110 as derived from plasmids pBM311 and pBI101.l.
  • the present invention provides nucleic acid promoter fragments of the Em gene of wheat which are responsive to compounds possessing ABA-like activity to bring the expression of DNA sequences for selected gene products under external control.
  • a major storage protein found in mature wheat embryos is synthesized early during the process of seed maturation. Its synthesis can be monitored by the accumulation of a radioactive amino acid
  • Em begins to accumulate in embryos by 21 days post anthesis, i.e.. Stage III. When embryos are removed from the grain at Stage II (15 days) or III and cultured in vitro, they germinate precociously into normal seedlings and Em is not accumulated. Williamson and Quatrano, Europ. J.
  • Em is one of a family of about 50 proteins that appear to be regulated in this manner by ABA.
  • the Em gene of wheat, encoding the Em protein includes the coding region for the protein, and all necessary regulatory sequences upstream (5') and downstream (3') and/or within the coding region, such as the upstream (5') promoter region.
  • Another storage protein from wheat embryos is included in this family (Williamson and Quatrano, Plant Physiol., 86:208-215 (1988)).
  • This globulin class of storage proteins has members in the monocot maize (Khavkin et al., Planta, 143:11-20 (1978)) and has been extensively studied and characterized in dicot seeds, especially the legumes (Casey et al., Oxford Surveys PI. Mol. Cell Biol., 3:1-95 (1986)). Based on the distribution of this class of storage proteins in seeds of many plants, we would expect that proteins and genes homologous to Em from wheat would be represented in all seed plants.
  • promoter region refers to a sequence of DNA, usually upstream (5') to the coding sequence, which controls the expression of the coding region by providing the recognition for RNA polymerase and/or other factors required for transcription to start at the correct site.
  • promoter fragment constitutes a fraction of the DNA sequence of the promoter region.
  • Nucleic acid refers to a large molecule which can be single-stranded or double-stranded, composed of monomers (nucleotides) containing a sugar, phosphate and either a purine or pyrimidine.
  • DNA deoxyribonucleic acid
  • RNA ribonucleic acid
  • nucleotide sequence refers to a polymer of DNA or RNA which can be single-stranded or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases capable of incorporation into DNA or RNA polymers.
  • DNA sequences for selected gene products refers to a gene of DNA sequences that codes for a specific protein.
  • regulatory sequence refers to a nucleotide sequence located upstream (5'), within, and/or downstream (3') to a DNA sequence for a selected gene product whose transcription and expression is controlled by the regulatory sequence in conjunction with the protein synthetic apparatus of the cell.
  • the term “recombinant DNA construct” refers to a plasmid, virus, autonomously replicating sequence, phage or nucleotide sequence, linear or circular, of a single-stranded or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product into a plant cell.
  • “monocotyledonous plant” or monocot refers to a plant whose seeds have only one cotyledon, or organ of the embryo which stores and absorbs food.
  • “dicotyledonous plant” or dicot refers to a plant whose seeds have two cotyledons.
  • a “protoplast” refers to a plant cell without a cell wall or extracellular matrix.
  • transformation means processes by which cell/tissue/plant acquire properties encoded on a nucleic acid molecule that has been transferred to the cell/tissue/plant.
  • Transferring refers to methods to transfer DNA into cells including microinjection, permeabilizing the cell membrane with various physical (e.g., electroporation) or chemical (e.g., polyethylene glycol, PEG) treatments, or by integration into the host nuclear DNA by the bacterial vector Agrobacterium tumefaciens.
  • various physical e.g., electroporation
  • chemical e.g., polyethylene glycol, PEG
  • exposing" a protoplast or a plant to a chemical substance refers to treating, incubating, contacting said protoplast or plant with the substance.
  • operably linked refers to the chemical fusion of two fragments of DNA in a proper orientation and reading frame to be transcribed into functional RNA.
  • homologous to refers to proteins or nucleic acids having similar sequences of amino acids or nucleotides respectively, i.e., proteins or nucleic acids with the same structural or functional properties.
  • expression is intended to mean the transcription and translation to gene product from a gene coding for the sequence of the gene product. In the expression, a DNA chain coding for the sequence of the gene product is first transcribed to a complementary RNA which is called a messenger RNA and, then, the thus transcribed messenger RNA is translated into the above-mentioned gene product.
  • transcription start codon refers to a unit of three nucleotides (codon) in a nucleic acid that specifies the initiation of the structural gene or protein sequence.
  • “Chemical inducers” are compounds which interact with promoters to trigger the expression of operably-linked structural genes, selected gene products or reporter genes such as GUS.
  • ABA-like compounds are compounds that mimic the effect of ABA in one or more physiological processes or bioassays, such as stomatal closure, bud/seed dormancy, inhibition of seed germination and responses of plants to physical stress (c.f. Addicott, Abscisic Acid. Praeger Publ., N.Y. 607 pp. (1983); Addicott and Lyon, Ann. Rev. Plant Physiol. 20:139-164 (1969); Zeevaart and Creelman, Ann. Rev. Plant Physiol. 39:439-473 (1988)).
  • Transformed plant cell(s) can include a protoplast(s) (plant cell without a cell wall) an isolated cell(s) or a cell(s) within a transformed plant.
  • restriction enzyme digestion buffers and digestion conditions used are those supplied by the manufacturer of each particular enzyme. When recommended by the manufacturer, dithiothreitol (DTT) is added from a separate sterile stock solution to the recommended concentration. Enzyme is added to give 5-10 units per microgram of DNA and the reaction mixture is adjusted to the appropriate final volume with H 2 O (usually 10-20 ⁇ l).
  • the restriction enzyme reaction mixtures used routinely contained 0.7-2.0 ⁇ g plasmid DNA. The reaction mixtures are mixed by vortexing and then incubated at the appropriate temperature for 1.5 hours. Digestion of DNA with multiple enzymes is done concomitantly when the optimal salt and temperature conditions of the separate enzymes are similar.
  • the fill-in reaction utilizes the Klenow fragment of E. coli DNA polymerase I.
  • the reaction mixture is 1 unit of Klenow fragment, 16 ⁇ M of deoxynucleotide triphosphates (dNTPs) (all four) in 10-50 mM Tris/HCl (pH 7.5-8.0), 0-50 mM NaCl and is performed at 37°C for 15 minutes.
  • dNTPs deoxynucleotide triphosphates
  • the reaction is performed in the same tube in which the reaction with the restriction enzyme(s) took place. In those cases, the salt concentration is adjusted to a final concentration of less than 50 mM.
  • the Klenow fragment is denatured by heating it to 65°C for 10 minutes to .avoid unwanted filling-in of secondary restriction site ends.
  • T4 DNA polymerase may be used for filling-in restriction sites which leave 5' overhangs and for chewing-back restriction sites which leave 3' overhangs.
  • the reaction mixture for both reactions is 10 units of T4 polymerase, 300 ⁇ M dNTPs (all four), 40 mM Tris/HCl (pH 7.5), 10 mM MgCl 2 , 5 mM DTT, 50 mM NaCl, 50 ⁇ g/ml bovine serum albumin (BSA) and is performed at 11°C for 20 minutes.
  • BSA bovine serum albumin
  • the T4 polymerase is denatured by heating to 75°C for 10 minutes to avoid unwanted filling-in or chewing-back of secondary restriction site ends.
  • This procedure is designed for the construction of fragments of DNA reduced by the progressive, unidirectional deletion of DNA. This is accomplished by digesting appropriately prepared DNA with exonuclease III (exoIII) and removing aliquots at increasing intervals of time during the digestion. The resulting successively smaller fragments of DNA may be sequenced to determine the exact endpoint of the deletions.
  • exonuclease III exoIII
  • There are several commercially available systems which use exonuclease III (exoIII) to create such a deletion series e.g. Promega-Biotec, Madison, WI 53711, Erase-A-Base System, Cat# E5750).
  • the procedure is performed as follows:
  • the DNA molecule of interest (usually a plasmid) must contain at least two unique restriction sites. One of these sites (the first) will be the one from which the deletion reaction will proceed and may be adjacent to or within the DNA to be deleted.
  • the second site must be in a position such that the first site lies between the second site and the DNA to be deleted.
  • the molecule is cleaved with the restriction enzymes (as described above) to prepare for the deletion reaction.
  • the restriction site from which the deletion is to proceed must produce a 5' protruding end or a blunt end (sensitive to exoIII digestion).
  • the other restriction site must either produce a 4 base 3' protruding end, or must be filled-in with ⁇ -phosphorothioate nucleotides (insensitive to exoIII digestion).
  • the plasmid is digested with this enzyme first. The ends will then be filled-in in the presence of 40 ⁇ M each of the four ⁇ -phosphorothioate nucleotides, 1 mM DTT, 20 mM Tris/HCl (pH 8.0), 100 mM MgCl 2 and 50 units/ml Klenow fragment at 37°C for 10 minutes.
  • the sample is then heated to 70°C to inactivate the Klenow fragment and the second restriction digestion is performed. If the second restriction enzyme is incompatible with the salt concentrations in the Klenow reaction, the sample must first be extracted with an equal volume of phenol :CHCl 3 :isoamyl alcohol (25:24:1), and the DNA isolated by precipitation from the aqueous phase by the addition of 2 volumes of ethanol. After the second restriction digestion is finished, the sample is extracted and the DNA again precipitated by addition of ethanol.
  • the exoIII digestion may now be performed on the isolated DNA.
  • the procedure outlined below is adapted for digesting approximately 5 ⁇ g of doublecut plasmid DNA and taking samples at 25 intervals of time: The DNA sample is dissolved in 60 ⁇ l of 1 x exoIII buffer (66 mM Tris/HCl (pH8.0), 6.6 mM MgCl 2 ) and 250-500 units of exoIII nuclease is added, mixed rapidly and the sample is incubated at 37°C.
  • SI nuclease mix consists of 40 mM potassium acetate (pH4.6), 0.33 mM NaCl, 1.35 mM ZnCl 2 , 6.67 mM glycerol containing 0.3 units of SI nuclease/ ⁇ l.
  • SI stop buffer 0.3 M Tris base, 50 mM ethylenediaminetetraacetic acid (EDTA) is added and the samples are heated to 70°C for 10 minutes. Aliquots (2 ⁇ l) are removed from the sample tubes and are analyzed on a 1% agarose gel to determine the extent of digestion. The remainder of each of the samples are transferred to 37°C and 1 ⁇ l of Klenow mix (1 x Klenow buffer-see above containing 0.10-0.15 unit Klenow fragment/ ⁇ l) is added. After a 3 minute incubation period, 1 ⁇ l of dNTP mix (0.125 mM each of each of the four dNTPs) is added and the incubation is continued for 5 additional minutes.
  • SI stop buffer 0.3 M Tris base, 50 mM ethylenediaminetetraacetic acid (EDTA) is added and the samples are heated to 70°C for 10 minutes. Aliquots (2 ⁇ l) are removed from the sample tubes and are analyzed on a 1% agarose gel to determine
  • ligase mix 50 mM Tris/HCl (pH 7.6), 10 mM MgCl 2 , 1 mM ATP, 5% PEG, 1 mM DTT containing 0.005 units T4 ligase/ ⁇ l
  • the tubes are mixed well and allowed to incubate at room temperature for 1 hour.
  • Tris-Borate-EDTA (TBE) buffer described by Bethesda Research Laboratories, Gaithersburg, MD 20877, which consists of 89 mM Tris-89 mM borate (pH 8.3), 2.5 mM Na 2 EDTA is used.
  • the gels used consisted of 5% acrylamide and 0.2% bis-acrylamide dissolved in 100 ml 1 x TBE. To this solution, 0.225 ml of an aqueous 25% ammonium persulfate solution is added. After adding 55 ⁇ l of N,N,N',N'-Tetramethylethylenediamine (TEMED), the solution is pipetted into a gel mold.
  • TEMED N,N,N',N'-Tetramethylethylenediamine
  • a 0.75 mm comb and 0.75 mm spacers are used and approximately 0.5-1.0 ⁇ g of DNA is loaded per well. Electrophoresis is carried out at 150-250 volts in 1 x TBE. After electrophoresis, the gel is stained in an aqueous solution of ethidium bromide (0.5 ⁇ g/ml) and the DNA is visualized on an ultraviolet transilluminator. The gel is photographed using a Polaroid camera and Polaroid 57 film (Polaroid Tech. Photo, Cambridge, MA 02139).
  • DNA is recovered from polyacrylamide gels as follows: the desired band, visualized by ethidium bromide staining, is cut from the gel, placed in an Eppendorf tube and minced with a teflon pestle. An equal volume of a 0.5 M ammonium acetate, 1 mM EDTA solution is added and the tube is incubated at 37°C overnight. The following day, the tube is centrifuged at 14,000 x g in a microfuge for 5 minutes at room temperature, the supernatant is removed, 1/2 volume of fresh elution buffer is added to the minced polyacrylamide and the contents are mixed by vortexing.
  • the tube is again centrifuged, as above, for 5 minutes and the supernatant removed and pooled with the supernatant from the first centrifugation.
  • the pooled supernatants are passed over a small glass wool column to remove any residual polyacrylamide gel pieces and the DNA in the sample is precipitated two times consecutively, each time by addition of 2 volumes of ethanol and incubation in dry ice-ethanol.
  • the DNA is collected by centrifugation of the sample in a microfuge, as above, for 15 minutes at room temperature. The pellet is then resuspended in the buffer of choice depending on the nature of the next manipulation.
  • Agarose gel electrophoresis of DNA is performed in 1% agarose gels using the buffer described above for polyacrylamide gels.
  • Ethidium bromide is added to the agarose to a final concentration of 0.5 ⁇ g/ml prior to pouring the gel. No ethidium bromide is included in the running buffer. After electrophoresis, the DNA is visualized on an ultraviolet transilluminator and photographed as described above. DNA is recovered from agarose gels by electroelution onto DEAE-cellulose paper (Schleicher & Schuell, Inc. Keene, NH 03431, Cat# NA45). The DNA is eluted from the paper by incubation at 65°C in 1 x Tris-EDTA (TE) (10mM Tris/HCl, 1 mM EDTA, pH 8.0) containing 150 mM NaCl for 15-20 minutes.
  • TE Tris-EDTA
  • the contents of the tubes are mixed by vortexing them for 30 seconds every 5 minutes of incubation.
  • the eluted DNA is precipitated by addition of 2 volumes of ethanol and incubation of the resultant mixture in a dry ice-ethanol bath until the contents in the sample becomes a slurry.
  • the DNA is pelleted by centrifugation of the tubes in a microfuge at 14,000 x g for 15 minutes at room temperature and resuspended in 150 ⁇ l TE.
  • the resuspended DNA is extracted once with phenol :ChCl 3 : isoamyl alcohol
  • aqueous phase is transferred to a fresh tube.
  • the aqueous solution is made 0.3 M with respect to sodium acetate by addition of 3.0 M sodium acetate and the DNA is precipitated by addition of 2 volumes of ethanol as before. After centrifugation, as already described, the resulting DNA pellet is resuspended in the appropriate buffer depending on the next manipulation.
  • a rich medium i.e., Luria-Bertani (LB) medium
  • OD @ 550 about 0.3
  • the bacterial cells are pelleted by centrifugation in a clinical centrifuge at 1,400 x
  • the cells are collected again by centrifugation as above and resuspended in 1/20 volume ice-cold CaCl 2 . These are now competent E. coli cells.
  • Ligation mixtures are diluted at least 50% with TE prior to adding competent E. coli cells. Typically, a 1, 2, and 5 ⁇ l aliqout of each ligation mixture is placed in pre-chilled, sterile Eppendorf tubes and TE is added to a final volume of 10 ⁇ l.
  • E. coli cells 200 ⁇ l of competent cells
  • the transformation tubes are heat shocked by incubation for 2 minutes at 42°C after which they are returned to ice for 2-3 minutes.
  • each transformation tube is spread on an LB-agar plate containing 100 ⁇ g/ml of ampicillin or the required amount of other antibiotics as appropriate (antibiotic plates).
  • the antibiotic-resistant cells which grow are analyzed for the presence of the appropriate DNA construct by isolation of plasmid DNA (small scale), restriction enzyme analysis (below) and by sequence analysis (below).
  • Plasmid-harboring strains of gram negative bacteria are grown to saturation overnight at 37°C in LB medium (described by Maniatis et al., Molecular Cloning: a Laboratory Manual, p 440, Cold Spring
  • the bacterial cells are harvested by centrifugation, as above, washed once with 10 mM MgSO 4 , collected again by centrifugation, then lysed by an alkaline lysis procedure essentially as described by Maniatis et al., supra. The procedure is as follows: The cells from a 500 ml culture are resuspended in 10 ml of ice-cold lysis solution and incubated at room temperature for 5 minutes.
  • Lysis solution consists of 50 mM glucose, 25 mM Tris/HCl (pH 8.0), 10 mM EDTA and 5 mg/ml of lysozyme, the lysozyme being added just prior to use. After the addition of 20 ml of a solution of freshly-made, ice-cold 0.2 N NaOH, 1% sodium dodecyl sulfate (SDS) the contents are thoroughly mixed and incubated on ice for 10 minutes. Then, 15 ml of a 5 M potassium acetate solution is added, and the contents are mixed by vortexing for 30 sec. The mixture is then incubated on ice for an additional 10 minutes.
  • SDS sodium dodecyl sulfate
  • the 5 M potassium acetate solution is prepared by addition of 60 ml of 5 M potassium acetate and 11.5 ml of glacial acetic acid to 28.5 ml of H 2 O.
  • the resulting solution is 3 M with respect to potassium and 5 M with respect to acetate.
  • the tubes are then centrifuged at 47,500 x g for 20 minutes at 4°C and the supernatant is transferred to a fresh tube.
  • Nucleic acid is precipitated from the supernatant by addition of 0.6 volumes of isopropanol followed by incubation for 15 minutes at room temperature.
  • the nucleic acid is pelleted by centrifugation at 12,000 x g at room temperature for 30 minutes. The supernatant is discarded and the remaining nucleic acid pellet is washed once with 70% ethanol. The pellet is resuspended in 5 ml TE, and further purified as described below.
  • the resulting plasmid DNA is purified by banding it two times successively in cesium chloride-ethidium bromide (0.97 g/ml and 0.43 g/ml respectively) equilibrium density gradients by centrifugation at 220,000 x g at 20°C for 14-18 hours.
  • the bands containing the plasmid DNA are removed from the tubes by inserting a 23 gauge needle (connected to a 5 ml syringe) through the side of the tube.
  • Ethidium bromide is removed from the sample by extraction with H 2 O-saturated n-butanol. The extraction is repeated until there is no longer a visible pink color in the aqueous phase.
  • the extracted plasmid DNA is mixed with 2.0 volumes H 2 O to dilute the CsCl. The sample is then mixed with
  • Bacteria from the same culture are streaked on an antibiotic plate and incubated at 37°C overnight. This is called a master plate and will be the source of bacteria for subsequent manipulations.
  • the cultures are processed as follows: A portion of each culture (typically 1.5 ml) is transferred to a 1.5 ml Eppendorf tube and the cells are harvested by centrifugation at 14,000 x g for 1 minute. The pelleted cells are resuspended in 100 ⁇ l of ice-cold, lysis solution (previously described) to which 4 mg/ml lysozyme is added just prior to use.
  • the tubes are incubated at room temperature for 5 minutes, then 200 ⁇ l of a solution of freshly-made, ice-cold 0.2 N NaOH, 1% SDS are added.
  • the tubes are mixed by inversion several times followed by incubation on ice for 5 minutes.
  • 150 ⁇ l of a 5 M potassium acetate solution (previously described) is added, and the contents of the tubes are mixed by vortexing for 10 seconds while the tubes are in an inverted position.
  • the tubes are then centrifuged at 14 , 000 x g for 5 minutes at 4°C.
  • the supernatant is transferred to a fresh tube and extracted with an equal volume of phenol :CHCl 3 : isoamyl alcohol (25:24:1).
  • the tubes are again centrifuged, as above, at room temperature for 5 minutes in a microfuge and the aqueous phase is transferred to a fresh tube.
  • the nucleic acid is precipitated from the solution by addition of 2 volumes of absolute ethanol, mixing by vortexing for 10 sec, and incubation for 2 minutes at room temperature.
  • the tubes are again centrifuged, as above, at room temperature for 5 minutes.
  • the ethanol is removed and the remaining nucleic acid pellet is washed once with 70% ethanol.
  • the pellet is resuspended in 50 ⁇ l of TE containing 20 ⁇ g/ml RNase A.
  • the presence of the desired plasmid is determined by digestion of a 10 ⁇ l aliquot of the recovered DNA with the appropriate restriction endonucleases. The fragments produced in the digestion are analyzed by electrophoresis on agarose or polyacrylamide gels as described above.
  • the master plate is used to initiate cultures originating from single colonies for large scale isolation of the plasmid and also for the preparation of bacterial stocks which are stored at -70°C in LB medium containing 20% glycerol.
  • Plasmid DNA was prepared as described above for large scale isolation.
  • the protocol used is a combination of the method of Zagursky, et al. (Gene Anal. Tech., 2:89-94 (1985)) and the method supplied with the Sequenase® Sequencing Kit (Cat. #70700) available commercially from U.S. Biochemical Corp., Cleveland, Ohio 44122.
  • the plasmid DNA is sequenced .as follows: Three ⁇ g of an aqueous plasmid sample, in a total volume of 8 ⁇ l, is placed into a tube, 2 ⁇ l of 2 N NaOH is added and mixed well.
  • the tubes are incubated at room temperature for 5 minutes after which 1 ⁇ l of a primer oligonucleotide, 6 ⁇ l of H 2 O, and 3 ⁇ l of 3 M NaOAc (pH 5.2) are added and the samples are mixed.
  • the plasmid and primer are co-precipitated by addition of 75 ⁇ l ethanol and incubation in a dry ice/ethanol bath for 20 minutes.
  • the nucleic acids are pelleted at 14,000 x g for 5 minutes at room temperature. The pellet is resuspended in 8 ⁇ l H 2 O and 2 ⁇ l of 5 x Sequenase® buffer is added.
  • Sequenase® buffer (5x) is 200 mM Tris/HCl pH7.5, 100 mM MgCl 2 , 250 mM NaCl. These are called the annealing tubes.
  • Termination mixes all contain 160 ⁇ M dITP, 80 ⁇ M dATP, 80 ⁇ M dCTP, 80 ⁇ M dTTP and 50 mM NaCl.
  • the G termination mix contains 1.6 ⁇ M ddGTP
  • the A termination mix contains 8 ⁇ M ddATP
  • the T termination mix contains 8 ⁇ M ddTTP
  • the C termination mix contains 8 ⁇ M ddCTP.
  • the contents of the labeling tubes are then aliquoted into the termination tubes, 3.5 ⁇ l into each (G, A, T, C), and the incubation is continued at 37°C for an additional 5 minutes. After the termination reaction, 4 ⁇ l of stop solution is added. Stop solution is 95% formamide, 20 mM EDTA, 0.05% bromphenol blue, and 0.05% xylene cyanol.
  • the samples are heated to 75°C for 2 minutes and electrophoresed on a 6% polyacrylamide sequencing gel.
  • the running buffer is also 1 x TBE.
  • the gel is electrophoresed at 22 mA (constant current), dried down on Whatman 3MM chromatography paper and exposed to Kodak XAR X-ray film for 1-2 days at room temperature.
  • Plasmid Constructions Plasmids may be constructed using restriction enzymes, polymerases and other procedures as described above and which are well known to those skilled in the art and described in Maniatis et al., supra.
  • the promoter fragments of DNA of this invention may be obtained by digesting plasmid pEAS41.8 which has been deposited in the American Type Culture Collection, Rockville, MD 20852-1776, accession number 67647, with the restriction endonucleases AhaII and SalI and isolating resulting DNA fragments with about 1500 and 354 bp.
  • the construct resulting from the linkage of the promoter fragment of DNA and a desired gene may be placed in a plasmid vector capable of growing in bacteria, for convenience in preparing quantities of the construct.
  • the 1850 bp promoter fragment of DNA may be further reduced in length to contain 640 bp, 254 bp or 50 bp by suitable enzymatic digestions, isolations and ligations.
  • said 640 bp, 254 bp and 50 bp promoter fragments retain their ability to respond to the presence of suitable concentrations of ABA.
  • the molecular manipulations of DNA to construct the plasmids disclosed below were done as described in the section above and include digesting DNA with specific endonucleases, isolating fragments from gels, filling-in certain restriction site overhangs, ligating desired DNA fragments, and transforming bacterial cells.
  • Several such plasmids are produced in the EXAMPLES but these are not meant to be all inclusive.
  • Rice suspension cultures initiated from immature embryos or anther-derived callus, are maintained by weekly subculture at a 1:4 dilution ratio with fresh liquid N6 medium as described by Chu et al., Sci Sinica 18: 659-668 (1975) containing 2 mg/ml 2,4-dichlorophenoxyacetic acid and 3% (w/v) sucrose, pH 6.0.
  • Protoplasts are isolated from suspensions of rice cells 4-6 days after subculture by overnight incubation (16-18 h) in 4 ml of enzyme solution per gram of cells and agitation of the mixture on a rotary shaker at 30 rpm at 25°C.
  • the enzyme solution contained 2% (w/v) cellulase "Onozuka” RS and 0.5% (w/v) Macerozyme (both from Yakult Honsha, Nishinomiya, Japan) and 13% (w/v) mannitol, pH 5.6.
  • Released protoplasts are filtered through a 60 ⁇ m mesh size nylon screen, transferred to 50 ml Pyrex test tubes and washed twice by centrifugation at 80 x g for 10 minutes in Krens' F solution (140 mM NaCl, 3.6 mM KCl, 0.75 mM Na 2 HPO 4 .7H 2 O, 5 mM glucose, 125 mM CaCl 2 , pH7.0).
  • Protoplasts are purified by resuspending the pellet in N6 medium with 17% (w/v) sucrose, centrifuging at 80 x g for 20 minutes and collecting the floating layer. Cell counts are made with a Fuchs-Rosenthal hemocytometer.
  • Protoplasts are transformed as follows: Protoplasts (1-5 x 10 ) are centrifuged gently (80 x g) for 2 minutes in sterile tubes. The supernatant is removed and discarded and the tubes are shaken gently to loosen the protoplasts from the bottom of the tube. The DNA sample, with which the protoplasts are to be transformed, in 5 ⁇ l or less of TE, is added to the protoplasts. The tubes are shaken gently to disperse the cells in the DNA solution then 100 ⁇ l of a solution containing 40% PEG (Polysciences Inc., Warrington PA 18976, CAT# 1102) and 3 mM CaCl 2 is added.
  • PEG Polysciences Inc., Warrington PA 18976, CAT# 1102
  • the resulting mixture is mixed gently for 10 seconds, then 1.0 ml of Krens' F solution is added to dilute out the PEG.
  • the tubes are incubated on ice for 15-20 minutes and then centrifuged at 80 x g for 4 minutes. The supernatant is removed and the protoplasts are washed once with 1.0 ml of a solution of Krens' F solution.
  • the protoplasts are resuspended in protoplast medium (0.2 mM KH 2 PO 4 , 1 mM KNO 3 , 1 mM MgSO 4 , 1 ⁇ M KI, 0.1 ⁇ M CuSO 4 , 10 mM CaCl 2 , 10% mannitol, pH 6.5) at a density of 1 x 10 protoplasts per ml and incubated at 25°C, in the dark, for the desired periods of time, with or without ABA, phaseic acid, Compound C or Compound D.
  • protoplast medium 0.2 mM KH 2 PO 4 , 1 mM KNO 3 , 1 mM MgSO 4 , 1 ⁇ M KI, 0.1 ⁇ M CuSO 4 , 10 mM CaCl 2 , 10% mannitol, pH 6.5
  • GUS Assay Protoplasts are harvested by centrifugation at 80 x g, and are resuspended in 0.5 ml lx GUS lysis buffer (50 mM NaPO 4 (pH 7.0), 10 mM 2-mercaptoethanol, 10 mM EDTA, 0.1% Triton X-100, 0.1% N-lauroylsarcosine). The suspension containing the lysed protoplasts is transferred to Eppendorf tubes and centrifuged in a microfuge at 14,000 x g for 10 minutes. It is possible to freeze the suspension of lysed cells in the extraction buffer if the assay is to be performed at a later date.
  • the substrate for the assay is 4-methyl-umbelliferyl- ⁇ -D-glucuronide (4-MUG) and was obtained from Sigma Chemical Co., St. Louis MO 63178, Cat# 9130) in 1 x GUS buffer. It is at a concentration of 1 mM in the assay.
  • One/tenth volume (45 ⁇ l) of a pre-warmed (37°C) 10 mM 4-MUG stock is added to the pre-warmed 405 ⁇ l protoplast extract, and a 100 ⁇ l aliquot is immediately transferred to a well of a 24-well microtiter dish containing 0.9 ml 0.2 M Na 2 CO 3 . Similar aliquots are removed at 0.5 hour, 1 hour, and 2 hours or at 1 hour, 2 hours and 4 hours, and the microtiter dishes are stored in the dark between time points. The dishes may be examined for the fluorescence of 4-methyl umbelliferone (4-MU), the product of enzyme digested 4-MUG, by means of an ultraviolet transilluminator.
  • 4-MU 4-methyl umbelliferone
  • the excitation wavelength should be set at 365 nm and the emission wavelength should be set at 455 nm.
  • Standards of 4-MU Sigma Chemical Co., Cat# 1508, are also measured on the fluorimeter (typically at concentrations of 100 nM and 1 ⁇ M) and the specific activity is calculated as the picomoles of 4-MU produced per ⁇ g protein per hour of assay.
  • inducible cereal promoters can be recognized in rice protoplasts using a transient assay, and if so, to quickly determine those sequences that are required for the induction.
  • a transient assay would allow the rapid screening of numerous analogs of a chemical inducer of gene expression such as ABA, to optimize structure/expression activity. Knowing that the induction works in rice cells, and that the key regulatory regions of the gene and specific moieties of the chemical inducer have been initially identified, one could introduce these sequences into a relatively few stable transformants of rice. Confirmation of the correlation between results obtained in transient expression systems with those from stable integration is provided by the Ebert et al. and Ellis et al. references discussed supra.
  • the main approach used to identify operative recombinant DNA constructs of general utility is to place regulatory sequences derived from monocots in cells that are easy to transform, i.e., dicots such as tobacco, to determine if their sequences are recognized in transgenic plants.
  • dicots such as tobacco
  • Ebert et al. and Ellis et al. references demonstrate that when a viral enhancer element was operably linked to a maize inducible promoter (Adhl), and this construct stably introduced into tobacco plants, stable transformants were successfully induced by low oxygen levels.
  • Em promoter from wheat (monocot), operably linked to the reporter gene GUS, into tobacco plants via the bacterial vector Agrobacterium tumefaciens to test for ABA induction of GUS in stable transformants (transgenic plants). Since Em gene expression was initially detected only in embryo tissue of wheat seeds in response to ABA, the regulatory sequences within the promoter may specify ABA-regulated expression only in embryo tissue. To determine if both these regulatory components of the Em promoter (i.e., tissue specificity and ABA inducibility) are represented in the same or different segments requires analyses of GUS expression throughout the life cycle of transgenic plants.
  • the regulatory sequence responsible for ABA induction can be determined from transient expression in single-celled protoplasts, those sequences responsible for tissue specificity must be determined in multi-cellular, transgenic plants.
  • ABA-regulatory regions of the Em promoter as defined in the transient assay
  • the region of the promoter responding to ABA in protoplasts includes that region regulating tissue specificity in transgenic plants.
  • these regulatory sequences from the monocot wheat are recognized and operable in the dicot tobacco.
  • ABA is a natural growth regulator found in all seed plants (c.f., Davies, P. (Ed.) Plant Hormones and Their Roles In Plant Growth and Development., Martinus Nijhoff Publ. (1987)). It is light sensitive and will have pronounced physiological effects when applied to certain plant parts (c.f., Zeevaart and Creelman, Ann. Rev.
  • ABA Plant Physiol., 39:439-473 (1988)).
  • ABA will cause stomates to close and thereby prevent gaseous exchange between the plant and the atmosphere.
  • ABA has also been shown to inhibit seed germination, and to play a role in bud/seed dormancy, leaf senescence and in responses of plants to various physical stresses such as temperature and water.
  • Numerous compounds have been described that mimic the effect of ABA on one or more of these processes (or any other ABA-mediated process) and are referred to as "ABA-like". If ABA-like compounds are to be used as chemical inducers of selected genes at all stages, their effects on these key physiological processes must be minimized or eliminated.
  • transient assay and the experiments with transgenic plants outlined above will provide excellent tests which will allow us to optimize for field applicability traits as well as gene inducibility effectiveness of chemical inducers that are ABA-like.
  • Compound C [2-fIuoro-5-1-hydroxy-2,6,6-trimethyl-4-oxo-cyclohex-2- en-1-yl/-3-methyl-2,4-pentadienoic acid] differs from ABA by addition of a fluorine molecule in the structure, possibly making it more light stable.
  • Compound D [1,4-dihydroxy- ⁇ ,2,6,6-tetramethyl-2-cyclohexane-1-penta-cis-2,trans-4-dienoic acid] differs in the introduction of a hydroxyl in place of an oxygen. Both of these compounds are structurally very similar to ABA and are functionally "ABA-like", i.e., they both inhibit seed germination. Jung and Grossman reported (J. Plant. Physiol. 121:361-367 (1985) and J. Agron. Crop Sci.
  • terpenoid derivatives are very "ABA-like" in their ability to produce certain physiological effects, e.g., stomatal closure, increase leaf senescence and increased chilling/freezing resistance (Flores et al., J. Plant Physiol. 132:362-369 (1988)).
  • terpenoid derivatives are described in two German patents by Bliesener et al. (1981 - DOS P 31 43 721) and Sauter et al. (1981 - DOS P 31 43
  • E. coli strain HB101 harboring the plasmid ⁇ RK2013, is used as a helper for the plasmid mobilization in a triparental mating.
  • LBA4404 is grown overnight at 28°C in 5 ml of minimal A-sucrose medium (37.5 mM (NH 4 ) 2 SO 4 , 1.65 mM KH 2 PO 4 , 300 mM K 2 HPO 4 , 8.5 mM sodium citrate, 1 mM MgSO 4 , 0.2% sucrose, 50 ⁇ g/ml thiamine).
  • the HB101 derivatives are grown at 37°C in Luria-Bertani (LB) broth containing the appropriate antibiotic for
  • the bacterial strains are mixed as follows: 100 ⁇ l of each of the HB101 derivatives and 200 ⁇ l of LBA4404 are placed in a 1.5 ml microcentrifuge tube, mixed well and pelleted gently. The bacterial pellet is resuspended in 50 ⁇ l LB broth and the mixture is pipetted onto a sterile nitrocellulose disk (Millipore HA type filters). Each nitrocellulose disk is transferred to a stack of 6-8 sterile Whatman #1 filter paper disks to remove the excess liquid from the culture and thereby concentrate the bacteria in the mixture. The nitrocellulose disks are then placed onto LB agar in a 150 mm petri dish and incubated for approximately 16 hours at 28°C.
  • the disk is sterily transferred to a 15 ml tube containing 5 ml 10 mM MgSO 4 .
  • the tube is vortexed to release the bacteria into the liquid.
  • the bacteria 100 ⁇ l and 50 ⁇ l aliquots
  • the bacteria are plated on 2 minimal A-sucrose plates containing the appropriate antibiotic(s) and incubated at 28°C for 3 days.
  • resistant colonies are selected and the presence of the desired construct is confirmed by preparation of plasmid DNA (small-scale procedure from above) followed by restriction enzyme analysis.
  • Recombinant DNA constructs are stably integrated into the nuclear DNA of tobacco via
  • Agrobacterium tumifaciens infection of tobacco leaf disks Standard aseptic techniques for the manipulation of sterile media and axenic plant/bacterial cultures are followed, including the use of a laminar flow hood for all transfers. Potted tobacco plants for leaf disk infections are grown in a growth chamber maintained for a 12 hour, 24°C day, 12 hour, 20°C night cycle, with approximately 80% relative humidity, under mixed cool white fluorescent and incandescent lights. Tobacco leaf disk infections are carried out essentially by the method of Horsch et al., Science. 227:1229-1231 (1985).
  • Young leaves, not fully expanded and approximately 6-10 cm in length are harvested with a scalpel from approximately 4-6 week old tobacco plants.
  • the leaves are surface sterilized for 20 minutes by submerging them in approximately 500 ml of a 10% Clorox, 0.1% SDS solution and then rinsing them 3 times with sterile deionized water.
  • Leaf disks, 8 mm in diameter, are prepared from whole leaves using a sterile paper punch.
  • Leaf disks are inoculated by submerging them for several minutes in 20 ml of a 1:20 dilution of an overnight YEB broth culture of Agrobacteria carrying the plasmid of interest. After inoculation, the leaf disks are placed in petri dishes containing .1N1B agar medium (Murashige Minimal Organics Medium (Gibco, Grand Island, N.Y. 14072) with 0.1 mg/l thiamine, 0.5 mg/l pyridoxine, 0.5 mg/l nicotinic acid, 8 gm/l agar, 0.1 mg/l naphthalene acetic acid (NAA), and 1 mg/l benzylaminopurine (BAP), pH 5.8). The plates are sealed with parafilm and incubated under mixed fluorescent and "Gro and Sho" plant lights (General Electric) for 3 days in a culture room maintained at approximately 25°C.
  • .1N1B agar medium Murashige Minimal Organic
  • the leaf disks are transferred to fresh .1N1B medium containing 500 mg/L cefotaxime and 100 mg/L kanamycin.
  • Cefotaxime is kept as a frozen 100 mg/ml stock and added aseptically (filter sterilized through a 0.45 ⁇ m filter) to the media after atuoclaving.
  • a fresh kanamycin stock (50 mg/ml) is made for each use and is filter sterilized into the autoclaved media.
  • Leaf disks are incubated under the growth conditions described above for 3 weeks and then transferred to fresh media of the same composition. Approximately 1-2 weeks later shoots which develop on kanamycin-selected explants are excised with a sterile scalpel and planted in MX- medium (.1N1B agar medium from above without hormones), containing 200 mg/l cefotaxime and 100 mg/L kanamycin. Shoots which root in kanamycin are transferred to soil and grown in a growth chamber as described above. As plants develop flower buds, each inflorescence is bagged to ensure self pollination.
  • Seeds of transformed plants are harvested at various developmental stages to assay for the expression of GUS. After removing the capsule from the plant, half the capsule wall is cut and removed using a sterile scalpel. Immature seeds are harvested by scraping them off the placenta into Ependorf tubes. This procedure is repeated for the other half of the capsule. Mature seed is freely released after forming a hole in the capsule wall. Seeds are ground in Ependorf tubes using disposable pestles (Kontes, Vineland, N.J. 08360) and 1 ml GUS lysis buffer. The samples are vortexed and then centrifuged at 14K rpm for 15 minutes. The supernatant is used for GUS enzyme assay and protein determination (see above).
  • Plasmid pDH5I was disclosed in Pietrzak, et al., Nucl. Acids Res., 14: 5857-5868 (1986) and served as the source of Cauliflower Mosaic Virus (CaMV) 35S promoter sequence, a polylinker sequence and the CaMV 35S 3' region.
  • Plasmid pRAJ260 served as the source of the E. coli uidA gene, which encodes a ⁇ -glucuronidase enzyme (GUS). This plasmid is described by Jefferson et al., Proc. Natl. Acad. Sci. (USA) 83: 8447-8451 (1986).
  • the coding sequence for the GUS gene was cleaved from the vector sequences by digesting pRAJ260 with the restriction enzyme PstI as described above. This digestion results in the GUS gene being present on a 1.8 kb fragment. One such fragment was then isolated from a 1% agarose gel, (described above) and ligated into Pstl-digested pDH51. Individual plasmids were analyzed until one was identified in which the PstI insert was present in the same 5' to 3' orientation as the 35S promoter. The resulting plasmid, pBM107, contains the E. coli gene for GUS located between the CaMV 35S promoter sequence and the CaMV 35S 3' sequence.
  • Plasmid pBM107 was then digested with the restriction enzymes Smal and SalI.
  • the 5' overhang of the SalI site was filled-in by incubation of the cleaved plasmid for 15 minutes at 37°C with the Klenow fragment of DNA polymerase I and 16 ⁇ M deoxynucleotide triphosphates (dNTPs).
  • dNTPs deoxynucleotide triphosphates
  • the 2099 bp KpnI fragment was cleaved from pBM108 with the restriction endonuclease KpnI, isolated on a 1 % agarose gel as described above, and inserted into plasmid pUC18 at its KpnI restriction endonuclease site.
  • the fragment was inserted in the opposite 5' to 3' orientation with respect to the lacZ gene which already resided in pUC18.
  • the resulting plasmid, pBM109 is extremely useful because of the presence of multiple unique restriction sites just 5' relative to the GUS gene. Putative promoter sequences may be cloned into these sites thereby allowing the use of the GUS assay as a means of delineating promoter activity.
  • Plasmid pBM109 has been deposited in the American Type Culture Collection (ATCC) Rockville, MD 20852-1776 on March 2, 1988 and bears the ATCC accession number 67648. The construction of this plasmid is diagrammed in Figure 2.
  • Plasmid pEAS41.8 was digested with the restriction endonuclease Ahall and the 5' overhang was filled-in as described. The plasmid was then digested with the restriction endonuclease SalI and electrophoresed on a 1% agarose gel. Two fragments were isolated: a SalI fragment of about 1500 bp and a Sall-Ahall fragment of 354 bp.
  • This 354 bp fragment corresponds to positions 981-1334 of Figure 3 and consists of 348 bp of Em promoter sequence plus 6 bp of Em coding region.
  • the 1500 bp SalI fragment represents sequences from position 981 in Figure 3 to a site about 1500 bp 5' of 981.
  • the plasmid pBM112 was constructed by ligating the 354 bp Sall/blunt-ended-Ahall fragment into Sall/Smal digested pBM109.
  • the 1500 bp SalI fragment was then ligated into SalI-digested pBM112.
  • a clone was identified in which the 1500 bp SalI fragment was in the proper orientation to the Sall/Ahall fragment and this plasmid is called pBM113.
  • the construction of this plasmid, which contains the approximately 1850 bp promoter fragment, is diagrammed in Figure 4.
  • This SalI-SalI-Ahall fragment insertion resulted in the translational initiation codon (ATG) of the Em gene coding region being 5' relative to and in frame with the translational initiation codon for the GUS gene. Therefore, this fusion created a gene whose protein product is a chimera containing 12 amino acids added to the natural amino terminus of GUS (assuming the plant translation initiation signals are preferentially recognized in plant systems).
  • Plasmid pBM109 was digested with 0.5 units KpnI/ ⁇ g DNA (total reaction volume 50 ⁇ l) and 10 ⁇ l aliquots of the reaction were removed at time points of 2, 5, 10, 20 and 30 minutes of digestion. The aliquots were placed in tubes pre-warmed to 70°C which contained 1 ⁇ l of 25 mM EDTA in agarose gel tracking dye. The aliquots remained at 70°C for 10 minutes to stop the reaction. The aliquots, which contained partial digestion products, were then electrophoresed on a 1% agarose gel. The band which corresponded to linearized pBM109 (4785 bp) was eluted as already described.
  • Plasmid pBM113 was digested with the restriction endonuclease KpnI. This generated a 652 bp fragment of DNA containing a portion of the approximately 1850 bp of DNA from the wheat genome present. This 652 bp fragment represents 640 bp of Em promoter sequence, 6 bp of Em coding region and 6 bp of polylinker sequence. This 640 bp promoter fragment corresponds to position 689 to 1328 in Figure 3. The 652 bp fragment was isolated and ligated into the linearized pBM109.
  • This ligation should, theoretically, contain four different constructs due to the presence of two KpnI sites in pBM109 and the possibility that the 652 bp fragment, having two identical ends, could have inserted in either orientation in either site. Two of these constructs were to be isolated, namely, those into which the KpnI fragment had been inserted 5' relative to the GUS gene coding region, one in each orientation. After transforming E. coli with the ligation mixture, the transformants were screened for the appropriate constructs by small scale plasmid isolation, etc. as described above.
  • the plasmid ⁇ BM113Kp contains the KpnI fragment in the forward orientation (with respect to the GUS gene) and has exactly reconstructed the junction found in the originating plasmid pBM113.
  • plasmid pBM113Kp is a derivative of the plasmid pBM109 into which the 652 bp KpnI fragment of pBM113 has been inserted into the KpnI site 5' relative to the initiation codon of the GUS gene.
  • the plasmid pBM311 contains the same 652 bp fragment in the same KpnI site but in the opposite orientation. The construction of these plasmids is diagrammed in Figure 5.
  • Plasmid pBM113 was subjected to exoIII-mediated digestion as described in the section entitled "Exonuclease Ill-Mediated Deletion". Plasmid DNA (10 ⁇ g) was cleaved with Hindlll to completion and the overhang was filled-in with ⁇ -phosphorothioate nucleotides as described. The reaction was then extracted and the DNA ethanol precipitated, as described. The linearized, filled-in DNA molecule was then cleaved with BolII, which cleaves 683 bp 5' relative to the KpnI site. The sample was extracted and precipitated as described above. This produced a molecule which was resistant to exoIII digestion at the Hindlll site but sensitive to exoIII digestion at the BglII site.
  • ExoIII digestion was performed on the prepared plasmid as described in the section entitled "Exonuclease Ill-Mediated Deletion” and aliquots were removed at 10 second intervals beginning at 40 seconds and continuing to 250 seconds.
  • E. coli cells were transformed with the ligated samples from each time interval, and the transformed cells were plated on LB plates containing 100 ⁇ g/ml ampicillin. The plates were incubated at 37°C overnight and placed at 4°C the following day.
  • Bacteria originating from individual transformants from the samples of the various time intervals were analyzed by isolation of plasmid DNA (small scale) and restriction enzyme digestion.
  • the isolated plasmids were digested with the restriction enzymes KpnI and PvuII concomitantly. These enzymes were chosen for the following reasons: 1. Deletions were not of interest until the KpnI site which defines the 5' border of the Em promoter fragment known to be present in pBM113Kp was lost. The loss of the KpnI site is indicative of the removal of sufficient DNA so that the fragment remaining has less of the promoter region than that in pBM113Kp.
  • the plasmids are named PBM113 ⁇ 220.10, pBM113 ⁇ 220.9, and pBM113 ⁇ 240.13.
  • the construction of these plasmids is diagrammed in Figure 6.
  • the ⁇ in the plasmid name refers to Deletion, and the number refers to the time interval (seconds) of digestion].
  • the endpoints of the deletions were determined by sequence analysis (see above) and found to be at -291 bp, -254. bp, and -192 bp from the translational initiation codon (ATG) of the Em gene, respectively. These positions correspond to positions 1038, 1075 and 1137 in Figure 3, respectively.
  • Plasmid pBM117 is a derivative of the plasmid ⁇ BM109 into which the promoter region of the 35S gene of CaMV has been cloned. This was done by cleavage of plasmid pDH51 with the restriction endonucleases NcoI and SmaI.
  • the overhang produced by NcoI cleavage was filled-in as described in the section entitled "Enzymatic Treatments of DNA”.
  • the resulting fragments of the cleavage reaction were separated by electrophoresis on a 1% agarose gel and a fragment 535 bp in length, containing the 35S promoter region, was isolated from the gel as described in the section entitled "Gel Electrophoresis of DNA”.
  • the plasmid pBM109 was cleaved with the restriction endonuclease SmaI which results in the linearization of the molecule.
  • the 535 bp fragment isolated as described in the previous paragraph was ligated (as described in the section entitled “Enzymatic Treatments of DNA”) into the Smal-cleaved pBM109.
  • a clone was identified which harbored a plasmid containing the 35S promoter fragment of DNA, 5' relative to the GUS encoding region of DNA, and in the proper orientation.
  • the construction of this plasmid is diagrammed in Figure 7.
  • Plasmid pRAJ275 served as the source of the ⁇ -glucuronidase gene (GUS) and has been described by Jefferson in Plant Molecular Biology Reporter 5:387-405 (1987).
  • the GUS gene in plasmid ⁇ RAJ275 differs from that in pRAJ260 in that the sequence surrounding the initiator codon ATG has been changed to introduce two new restriction sites. SalI, and NcoI and in the introduction of a single restriction site for the restriction enzyme EcoRI at the 3' end of the gene.
  • the NcoI site contains the translational start codon (ATG) and is flanked immediately 5' by the SalI site.
  • the GUS gene was cleaved from plasmid pRAJ275 by sequential cleavage of the plasmid, as described above, with SalI, after which the SalI site was filled-in as described above, followed by cleavage with EcoRI. This digestion results in the GUS gene being on a 1857 bp fragment.
  • One such fragment was isolated from a 1% agarose gel (described above) and ligated into pUC18 which had been cleaved identically as was pRAJ275 (i.e., SalI digestion, after which the end was filled-in, followed by EcoRI digestion).
  • Individual plasmids were analyzed until one was identified which carried the GUS gene and the resulting plasmid is pBM119. The construction of this plasmid is diagrammed in Figure 8.
  • Plasmid pDH51 which served as the source of the 35S 3' sequences, was cleaved with the restriction enzymes NcoI and SphI after which the ends of the fragment were treated with T4 polymerase, as described, to create blunt ends.
  • This treatment results in the liberation of a 568 bp fragment containing the 35S promoter region plus the polylinker region of pDH51 and a 2857 bp fragment consisting of the remainder of pDH51, which carries the 35S 3' end.
  • the 2857 bp fragment was isolated from a 1% agarose gel, ligated, and individual plasmids were screened for the presence of a 214 bp EcoRI fragment which would carry the 35S 3' region.
  • the resulting plasmid is pCS102.
  • the construction of this plasmid is diagrammed in Figure 9.
  • Plasmid pCS102 was cleaved with EcoRI and the 214 bp fragment carrying the 35S 3' end was isolated on a 1% agarose gel and ligated into EcoRI-cut pBM119. Individual plasmids were analyzed until one was isolated which carried the 35S 3' region 3' of the GUS gene and in the proper 5' to 3' orientation. The resulting plasmid is pBM120 and the construction of this plasmid is diagrammed in Figure 9.
  • EXAMPLE 5 Construction of Plasmids pBM165 and PBM167
  • the series of plasmids designated pBM165 are derivatives of plasmid pDH51 into which an oligonucleotide (oligo) has been inserted into the 35S promoter region.
  • the oligonucleotide was inserted into the EcoRV site at -90 bp from the start of transcription from the 35S promoter.
  • the oligonucleotide was synthesized using an ABS DNA Synthesizer and includes a 25 bp region of the Em promoter bearing sequence homology to a region of a conglycinin promoter plus 19 bp of contiguous Em 5' flanking sequences and 7 bp of contiguous Em 3' flanking sequences.
  • This 50 bp promoter sequence corresponds to coordinates 1091 to 1140 in Figure 3.
  • the ends of the oligo contain 1/2 an EcoRV site such that the oligo may be inserted into the EcoRV site and excised with the same enzyme. Therefore, the oligo is 56 bp in length, and is hereafter referred to as "the 56 bp oligo".
  • the plasmid pDH51 was digested with the restriction enzyme EcoRV and ligated in the presence of the 56 bp oligo. Individual plasmids were analyzed for the presence of the oligo and plasmids were isolated in which the orientation and copy number of the oligo are as follows: pBM165-2: This plasmid contains a single copy of the oligo in the same 5' to 3' orientation as the sequence occurs in the Em promoter. pBM165-4: This plasmid contains two copies of the oligo, both of which are in the same 5' to 3' orientation as the sequence occurs in the Em promoter (i.e., head-to-tail).
  • Plasmid pBM165-2 has been deposited in the American Type Culture Collection (ATCC), Rockville, MD 10852-1776 on September 15, 1988 and bears the ATCC accession number 67797.
  • the series of plasmids designated pBM167 are derivatives of pBM120 into which the 35S promoter regions from the plasmids pBM165-2 and pBM165-4 have been inserted.
  • Plasmid pBM120 was cleaved with the restriction enzyme SalI and the ends of the plasmid were filled-in as described.
  • the plasmids pBM165-2 and pBM165-4 were cleaved with the restriction enzymes Smal and EcoRI after which the EcoRI ends of the plasmid were filled-in as described.
  • plasmids are the ⁇ BM167 series and they are as follows: pBM167-11: This plasmid contains the promoter region from the plasmid pBM165-2. pBM167-4: This plasmid contains the promoter region from the plasmid pBM165-4.
  • Plasmid series pBM165 and plasmid series pBM167 are diagrammed in Figure 10.
  • the 35S promoter, not containing the 56 bp oligo, was isolated from pDH51 and inserted into plasmid pBM120 exactly as described for the construction of the plasmid series pBM167 above.
  • the resulting plasmid is pBM152 and the construction of this plasmid is diagrammed in Figure 11.
  • Binary plasmids are plasmids which may be propagated in several hosts. Many plasmids of this type are useful for the Agrobacterium-mediated transformation of certain species of plants, especially tobacco. Binary constructs were made for the stable transformation of tobacco with several of the promoter-GUS constructs used in the transient system described above. The binary vector used for the construction of these binary plasmids was pBI101.1 and has been described by Jefferson et al. EMBO 6:3901-3907 (1987). Plasmid pBI101.1 is a derivative of plasmid pBIN19 into which a "promoter-less" GUS cassette has been inserted.
  • this plasmid has a plant selectable marker, in the form of a neomycin phosphotransferase gene (nptll), driven by the nopaline synthase promoter, which encodes resistance to the antibiotic kanamycin.
  • nptll neomycin phosphotransferase gene
  • All constructs were made by the ligation of gel-purified Hindlll/EcoRI fragments. Digestion of pBI101.1 with these two enzymes results in the liberation of an approximately 2 kbp fragment containing the "promoter-less' GUS cassette from the vector. This fragment is not used in the constructs. The remaining vector fragment (approximately 10 kbp) was gel purified as described above.
  • Digestion of plasmid pBM117 with the same two enzymes results in the liberation of a 2687 bp fragment from the vector sequences containing a 35S promoter-GUS-35S 3' cassette.
  • This 2687 bp fragment will be called fragment A.
  • digestion of the plasmids pBM113Kp and pBM311 with the same enzymes results in the liberation of 2802 bp fragments from the vector sequences.
  • These fragments (B and C, respectively) contain., the Em promoter-GUS-35S 3' cassettes with the Em promoter in the forward orientation in fragment B and in the reverse orientation in fragment C.
  • the protoplasts were collected by centrifugation at 80 x g.
  • the protoplast medium was removed from the tubes and the cells were lysed by addition of 0.5 ml of GUS lysis buffer as described in the section entitled "GUS Assay”.
  • Each culture of lysed protoplasts was then assayed for GUS activity as described above in the section entitled "GUS Assay”.
  • the specific plasmid DNA with which the protoplasts were transformed, the presence or absence of ABA, the concentrations of ABA in which the cultures were incubated and the results from the assay are given below in Table 1.
  • Em promoter-GUS construct The level of induction of the Em promoter-GUS construct is dependent on the concentration of ABA in the medium (Treatment Samples 3-5).
  • the source of protoplasts used for transformation is identical to that used in EXAMPLE 7. Protoplasts either did not receive added DNA or they were transformed with plasmid DNA as described in the section entitled "Transformation of Protoplasts".
  • a culture containing 2 x 10 6 protoplasts was transformed with 2 ⁇ g of plasmid DNA then divided and incubated as the cultures above which did not receive DNA (i.e.; the four samples were harvested either immediately after addition of protoplast medium (one each without ABA and with ABA) or at 6 hours (again, one each, without ABA and with ABA)).
  • the plasmid pBM113 contains the 1850 bp promoter sequence of this invention operably linked to the GUS gene.
  • a protoplast suspension containing 5 x 10 6 protoplasts was transformed by the addition of 5 ⁇ g of plasmid DNA during the transformation protocol. The protoplast suspension was split into 2 equal aliquots (2.5 x 10 6 protoplasts each), one without ABA and one with ABA (10 -5 M) and incubated as described.
  • the protoplasts for this example are from the same source as that for EXAMPLE 7.
  • Protoplasts were transformed with either calf thymus (CT) DNA, with pBM113 plasmid DNA or pBM117 plasmid DNA by the procedure described in the section entitled "Transformation of Protoplasts".
  • CT DNA is non-specific DNA derived from calf thymus and is used as a negative control in protoplast transformation.
  • Protoplast suspensions containing 1 x 10 6 protoplasts were used.
  • Protoplast suspensions receiving CT DNA were transformed by the addition of 25 ⁇ g of CT DNA and those being transformed with DNA from pBM117 received 5 ⁇ g plasmid DNA and 20 ⁇ g of CT DNA.
  • Protoplast suspensions to be transformed with DNA from plasmid pBM113 contained 2.0 x 10 6 protoplasts, 10.0 ⁇ g plasmid DNA and 15 ⁇ g CT DNA. After the transformation procedure, the suspensions transformed with CT DNA and DNA from pBM117 were each divided into two equal aliquots (0.5 x 10 6 protoplasts each) and incubated in protoplast medium. One aliquot was without ABA while the other contained 10 -4 M ABA. The suspension transformed with DNA from pBM113 was divided into 3 aliquots (0.5 x 10 6 protoplasts each) and similarly incubated in protoplast medium either without ABA, with 10 -4 M ABA or with 10 -4 M phaseic acid (PA). After the incubation period (4 hours), the protoplasts in each culture were collected by centrifugation and stored at -70°C in GUS lysis buffer. All aliquots were later assayed for enzyme activity. The results are shown in Table 3.
  • phaseic acid a structural analog and the first breakdown product of ABA in vivo, does not induce expression of the Em promoter-GUS construct. This is consistent with previous results in which phaseic acid does not mediate the in vivo physiological effects attributed to ABA in wheat embryos, i.e., phaseic acid does not inhibit seed germination.
  • Non-specific, non-plant DNA (CT) did not respond to ABA.
  • the source of protoplasts for this example is the same as that used in EXAMPLE 7.
  • several cultures, each containing 2 x 10 6 protoplasts either received no DNA or were transformed, as described in EXAMPLE 7, with plasmid DNA (2 ⁇ g) of the plasmids pBM117, pBM113, pBM113Kp or pBM311.
  • plasmid DNA (2 ⁇ g) of the plasmids pBM117, pBM113, pBM113Kp or pBM311.
  • Those suspensions which did not receive DNA, or received either pBM117 DNA or pBM311 DNA were divided into 2 equal aliquots after the transformation protocol, placed in protoplast medium, and incubated for 18 hours either in the presence of 10 -4M ABA or without added ABA. Transformations with pBM113 and pBM113Kp were each done in duplicate and the duplicates were pooled.
  • the pooled duplicates were then split into four (4) equal aliquots.
  • the transformed protoplasts were incubated for 18 hours in protoplast medium at
  • the protoplast medium contained the concentration of ABA shown in the table below.
  • the plasmid pBM113Kp which contains only 652 bp of the Em promoter region, behaves similarly to the plasmid pBM113, which contains approximately 1850 bp of the Em promoter region (Treatment Samples 5-8; 9-12).
  • Plasmid pBM311 which contains only 652 bp of the Em promoter region linked to GUS in the wrong orientation (unoperably linked), did not significantly express GUS activity when treated with ABA (Treatment Samples 13-14). Furthermore, the low levels of activity seen with the same promoter fragment operably linked to GUS (pBM113Kp) when incubated without ABA, is totally abolished when pBM311 is used (compare Treatment Samples 9 and 13)
  • the source of protoplasts for this EXAMPLE is the same as that used in EXAMPLE 7. Transformations were performed using 2 x 10 6 protoplasts and 2 ⁇ g of plasmid DNA (except for the control samples which did not receive DNA). Each suspension of transformed protoplasts was split equally (1 x 10 6 protoplasts) into protoplast medium either without ABA or with 10 -4M ABA and incubated at 25°C in the dark for 18 hours. The protoplasts were then collected and assayed for GUS activity. The results are given in
  • Plasmids containing fragments of the Em promoter to -291 bp (pBM113 ⁇ 220.10) and -254 bp (pBM113 ⁇ 220.9) 5' from the translation start codon (ATG) operably linked to GUS still retain the ability to be induced by ABA (Treatment Samples 3 and 4; 5 and 6).
  • a plasmid containing a fragment of the Em promoter to -192 bp (pBM113 ⁇ 240.13) 5' from the translation start codon (ATG) operably linked to GUS cannot be induced by ABA (Treatment Samples 7 and 8).
  • Plasmids pBM113 ⁇ 220.9 and pBM113 ⁇ 240.13 define a region of 62 bp in the Em promoter (-192 to -254) at least part of which is necessary for the ABA induction (ABA regulatory region).
  • EXAMPLES 12/13 Effect of two ABA analogs (Compounds C and D) on Em Promoter
  • the source of protoplasts for this EXAMPLE is the same as in EXAMPLE 7.
  • the transformation was performed in duplicate using 50 x 10 6 protoplasts and 100 ⁇ g of plasmid DNA.
  • the transformed protoplasts were split four ways and incubated in culture medium containing either ABA, Compound C, Compound D, or with no additions, at 25oC in the dark for 18 hours.
  • the protoplasts were then collected and assayed for GUS activity as described. The results are given in Table 6.
  • EXAMPLE 14 The results from EXAMPLE 11 clearly demonstrate that at least part of the DNA sequences necessary for ABA-mediated regulation of gene expression reside in a 62 bp region between -192 and -254 bp from the ATG codon of the Em coding region (as defined by plasmids pBM113 ⁇ 240.13 and pBM113 ⁇ 220.9, respectively).
  • ⁇ -conglycinin expression is also developmentally regulated by ABA (see page 4).
  • This region of homology is at the promoter proximal end of, and is completely contained within, the 62 bp region. The presence of this region of homology prompted the synthesis of the 56 bp oligo (see above). The introduction of the 56 bp oligo into a foreign promoter will cause expression from the foreign promoter to be influenced by ABA.
  • the protoplasts for this example are from the same source as that for EXAMPLE 7.
  • Protoplasts were transformed with either no DNA, with pBM117 plasmid DNA, or with pBM167 plasmid DNA by the procedure described in the section entitled "Transformation of Protoplasts".
  • the pBM167 series of plasmids is as described in EXAMPLE 5.
  • Protoplast suspensions containing 4 x 10 6 protoplasts were used and were transformed by the addition of either no DNA or by the addition of 4 ⁇ g plasmid DNA. After the transformation procedure, the suspensions were divided into two equal aliquots (2 x 10 6 protoplasts each) and incubated in protoplast medium. One aliquot of each sample was incubated without ABA while the other was incubated with 10 -4 M ABA. After the incubation period, the protoplasts in each culture were collected by centrifugation and lysed by addition of
  • Binary plasmids containing the plasmids pBM1170 ( 35 S-GUS) and pBM1130 (Em-GUS) were introduced into the Gram-negative bacterium Agrobacterium tumefaciens by the method of triparental mating and subsequently introduced into tobacco tissue by the leaf disk transformation protocol.
  • Transgenic tobacco plants were selected and grown as described earlier. At various times after flowering, seeds at different stages of maturation were collected and assayed for GUS activity. Detailed procedures are described in the section "Stable Transformation of Tobacco".
  • PBM1170 (Samples 1-3) show similar levels of accumulated GUS activity in seeds at various stages of maturity; from the very immature (white seeds), the immature (tan seeds) and the dry mature seed (dark brown). 35S is a constitutive promoter in higher plants and clearly shows its predicted activity throughout seed development.
  • Tobacco plants transformed with plasmid pBM1130 show increasing amounts of accumulated GUS activity in seeds at later stages of maturation. This pattern of GUS accumulation in later stages of transgenic tobacco seeds is similar to increasing Em expression in normal wheat seeds indicating that the fragment of the Em promoter (650 bp) linked to GUS is being regulated in a manner predictable from its normal expression in wheat. 3.
  • the Em promoter fragment from wheat (monocot) is recognized and regulated in a normal pattern in tobacco (dicot), presumably by the increasing endogenous levels of ABA occurring in late seed development.
  • EXAMPLE 16 Expression of GUS activity in transgenic tobacco seeds in response to ABA
  • Binary plasmids pBM1170 (35S-GUS), pBM1130 (Em-GUS) and pBM3110 (mE-GUS) were introduced into Agrobacterium and used to transform tobacco leaf disks by the methods outlined in EXAMPLE 15 and in the section Stable Transformation of Tobacco. Immature seeds (tan in color) were removed from the capsule as described in Stable Transformation of Tobacco and incubated for 24 hours on MX-medium with or without ABA.
  • Results 1) and 2) demonstrate the ability of the transient assay to accurately predict expression of GUS in transgenic plants.
  • the EM promoter fragment from wheat (monocot) is recognized and regulated by ABA in transgenic tobacco (dicot) in the same manner as in wheat, i.e., isolated immature wheat embryos when treated with ABA express the Em gene.
  • Em protein of wheat has been implicated in protection of the embryo during seed desiccation (McCubbin et al., Can. J. Biochem. Cell Biol., 63:803-811 (1985) and Litts et al., Nucl. Acids Res. 15:3607-3618 (1987)).
  • Em Normally during the life cycle of the wheat plant, Em is accumulated only in the embryo of seeds. It will be valuable to express this protein, with its natural ability to bind water, not just in seeds but in whole plants or specific tissue(s) that are experiencing unpredictable drought or water stress. Such expression and accumulation of the Em protein will allow the plant or its affected parts to retain water. We will use the information gained in the construction of this invention to protect plants under drought conditions.
  • a general response of plants to water stress or drought is to accumulate large amounts of ABA in affected tissue (e.g., Guerrero and Mullet, Plant Physiol. 80:588-591 (1986)).
  • the ABA regulatory region of the Em promoter will be used to over-produce the Em protein under conditions of water stress, resulting in the plant becoming tolerant to these adverse conditions.
  • Example 14 we described a "56 bp oligo", containing a 50 bp region of the wheat Em promoter, that was sufficient for ABA regulation of GUS.
  • this inducible ABA regulatory region of the Em promoter With the constitutive 35S promoter of CaMV by synthesizing the 56 bp oligo such that it can be inserted into the EcoRV site present in the 35S promoter.
  • the 35S promoter will provide the polymerase binding sequences necessary for transcription that have been removed from the ABA regulatory fragment.
  • This chimeric promoter will then be operably linked to the coding region of Em.
  • Such a construct when stably transformed into plants, will direct the low level expression of the Em protein constitutively throughout the plant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

On décrit la préparation et l'utilisation de fragments promoteurs de l'acide nucléique homologues du gène Em du blé et qui servent à soumettre l'expression de gènes sélectionnés dans des plantes à une régulation extérieure. Le fragment promoteur Em est sensible à l'acide abscisique (ABA) et à d'autres composés qui présentent une activité similaire à celle de l'ABA. En transformant des protoplastes et des cellules végétales avec des constructions d'ADN recombinant qui comprennent ces fragments promoteurs, on obtient l'expression de gènes sélectionnés fonctionnellement liés, en réponse à l'ABA et à des composés présentant une activité similaire à celle de l'ABA. On décrit également l'application de ces fragments promoteurs et de ces constructions dans des systèmes d'essai transitoires afin de prévoir les probabilités d'une transformation stable des plantes.
EP89904391A 1988-03-29 1989-03-15 Fragments promoteurs de l'adn du ble Withdrawn EP0409869A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17474488A 1988-03-29 1988-03-29
US174744 1988-03-29
US24718588A 1988-09-21 1988-09-21
US247185 1988-09-21

Publications (1)

Publication Number Publication Date
EP0409869A1 true EP0409869A1 (fr) 1991-01-30

Family

ID=26870511

Family Applications (2)

Application Number Title Priority Date Filing Date
EP89904391A Withdrawn EP0409869A1 (fr) 1988-03-29 1989-03-15 Fragments promoteurs de l'adn du ble
EP89302566A Pending EP0335528A3 (fr) 1988-03-29 1989-03-15 Fragments promoteurs d'ADN à partir du blé

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP89302566A Pending EP0335528A3 (fr) 1988-03-29 1989-03-15 Fragments promoteurs d'ADN à partir du blé

Country Status (7)

Country Link
EP (2) EP0409869A1 (fr)
JP (1) JPH03504318A (fr)
AU (1) AU626012B2 (fr)
DK (1) DK232690A (fr)
IL (1) IL89606A0 (fr)
NZ (1) NZ228320A (fr)
WO (1) WO1989009267A2 (fr)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550318A (en) * 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US6803499B1 (en) 1989-08-09 2004-10-12 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US6777589B1 (en) 1990-01-22 2004-08-17 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US6329574B1 (en) 1990-01-22 2001-12-11 Dekalb Genetics Corporation High lysine fertile transgenic corn plants
US6946587B1 (en) 1990-01-22 2005-09-20 Dekalb Genetics Corporation Method for preparing fertile transgenic corn plants
HU220773B1 (hu) 1990-01-22 2002-05-28 Dekalb Genetics Corporation Eljárás termő transzgenikus kukoricanövények előállítására
US6395966B1 (en) 1990-08-09 2002-05-28 Dekalb Genetics Corp. Fertile transgenic maize plants containing a gene encoding the pat protein
IL101508A0 (en) * 1991-04-08 1992-12-30 Rhone Poulenc Agrochimie Chimeric plant genes based on upstream regulatory elements of helianthinin
US5837545A (en) * 1993-01-21 1998-11-17 Research Corporation Technologies, Inc. Genes, polypeptides, and compositions for cold tolerance in plants
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
US5780709A (en) * 1993-08-25 1998-07-14 Dekalb Genetics Corporation Transgenic maize with increased mannitol content
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
ZA953474B (en) * 1994-04-29 1996-04-10 Dekalb Genetics Corp Genes regulating the response of Zea Mays to water deficit
US6048973A (en) * 1997-03-24 2000-04-11 The Regents Of The University Of California Sugar-regulatory sequences in alpha-amylase genes
AU7564898A (en) * 1997-05-07 1998-11-27 E.I. Du Pont De Nemours And Company Starch biosynthetic enzymes
CA2376383C (fr) 1999-06-07 2009-11-17 Basf Plant Science Gmbh .delta.6-acetylenase et .delta.6-desaturase obtenues a partir de ceratodon purpureus
DE19926770A1 (de) 1999-06-11 2000-12-14 Basf Ag Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen
DE10030976A1 (de) 2000-06-30 2002-01-10 Basf Ag DELTA6-Desaturasegene exprimierende Pflanzen und PUFAS enthaltende Öle aus diesen Pflanzen und ein Verfahren zur Herstellung ungesättigter Fettsäuren
MXPA02007078A (es) 2000-02-09 2003-03-27 Basf Ag Nuevo gen de elongasa y procedimiento para la obtencion de acidos grasos poliinsaturados.
US7456335B2 (en) 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
GB2385852A (en) 2002-02-27 2003-09-03 Rothamsted Ex Station Delta 6-desaturases from Primulaceae
DE10212158A1 (de) 2002-03-19 2003-10-02 Metanomics Gmbh & Co Kgaa Population transgener Pflanzen, davon abgeleitetes biologisches Material, entsprechende Plasmidkollektion und Population transformierter Wirtsorganismen, sowie deren Verwendung und Verfahren zu deren Erzeugung
DE10212892A1 (de) 2002-03-20 2003-10-09 Basf Plant Science Gmbh Konstrukte und Verfahren zur Regulation der Genexpression
CA2484001A1 (fr) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Procede pour augmenter la teneur en huile dans des vegetaux
CA2493364A1 (fr) 2002-07-26 2004-02-12 Basf Plant Science Gmbh Nouveaux procedes de selection
US20060064784A1 (en) 2002-08-07 2006-03-23 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response
AU2003294924A1 (en) 2002-12-20 2004-07-14 Metanomics Gmbh & Co. Kgaa Method for producing aminoacids
BRPI0407514A (pt) 2003-02-17 2006-02-14 Metanomics Gmbh método para preparar um organismo não humano, polinucleotìdeo, método para preparar um vetor, vetor, célula hospedeira, polipeptìdeo, anticorpo, ácido polinucléico de anti-sentido, método para preparar uma planta, célula vegetal, tecido vegetal transgênicos, célula de um animal útil, animal útil ou um microorganismo transgênico organismo não humano, microorganismo transgênico, rendimento ou um material de propagação de uma planta ou de um animal útil, biomassa de um microorganismo, método para preparar produtos quìmicos finos, e, uso de polipeptìdeo
AU2004215705B2 (en) 2003-02-27 2009-11-12 Basf Plant Science Gmbh Method for the production of polyunsaturated fatty acids
EP3121269A1 (fr) 2003-03-31 2017-01-25 University Of Bristol Nouvelles acyltransferases vegetales specifiques aux acides gras insatures multiples a chaine longue
WO2004092398A2 (fr) 2003-04-15 2004-10-28 Basf Plant Science Gmbh Sequence d'acides nucleiques codant pour des proteines associees a la reponse de stress abiotique et cellules vegetales et plantes a tolerance accrue au stress environnemental
EP1654368A2 (fr) 2003-08-01 2006-05-10 BASF Plant Science GmbH Procede de production de composes chimiques fins
CA2998666C (fr) 2003-08-01 2022-04-12 Basf Plant Science Gmbh Methode de production d'acides gras multiplis insatures dans un organisme transgenique
MXPA06001622A (es) 2003-08-11 2006-07-03 Kweek En Researchbed Agrico Bv Plantas resistentes a hongos y sus usos.
ATE440947T1 (de) 2003-12-02 2009-09-15 Basf Se 2-methyl-6-solanylbenzochinon-methyltransferase als ziel für herbizide
EP1720988B1 (fr) 2004-02-27 2011-10-12 BASF Plant Science GmbH PROCEDE POUR PRODUIRE DES ACIDES GRAS omega-3 INSATURES DANS DES ORGANISMES TRANSGENIQUES
US9458436B2 (en) 2004-02-27 2016-10-04 Basf Plant Science Gmbh Method for producing polyunsaturated fatty acids in transgenic plants
CA2559760A1 (fr) 2004-07-02 2006-07-06 Metanomics Gmbh Procede de production de produits chimiques fins
WO2007087815A2 (fr) 2004-12-17 2007-08-09 Metanomics Gmbh Procédé de contrôle de production de produits chimiques fins
WO2006013010A2 (fr) 2004-07-31 2006-02-09 Metanomics Gmbh Preparation d'organismes a croissance plus rapide et/ou a meilleur rendement
WO2006013072A2 (fr) 2004-08-02 2006-02-09 Basf Plant Science Gmbh Procede pour l'isolement de sequences de terminaison de transcription
EP1794184A2 (fr) 2004-09-24 2007-06-13 BASF Plant Science GmbH Sequence nucleotidiques codant des proteines associees a une reponse au stress abiotique et cellules de plante et plantes a tolerance accrue au stress environnemental
US20140199313A1 (en) 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
EP2194140A2 (fr) 2005-03-02 2010-06-09 Metanomics GmbH Procédé de production de produits chimiques fins
EP2169058B1 (fr) 2005-03-08 2013-01-23 BASF Plant Science GmbH Expression à amélioration de séquences d'intron
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
EP1874936B1 (fr) 2005-04-19 2013-10-30 BASF Plant Science GmbH Méthodes améliorées controlant une expression génique
AU2006260924B2 (en) 2005-06-23 2011-03-03 Basf Plant Science Gmbh Improved methods for the production of stably transformed, fertile zea mays plants
US8119858B2 (en) 2005-07-06 2012-02-21 Cropdesign N.V. Plant yield improvement by Ste20-like gene expression
CA2619411A1 (fr) 2005-08-12 2007-02-22 Basf Plant Science Gmbh Sequences d'acides nucleiques codant des proteines associees a la reponse au stress abiotique, cellules vegetales et vegetaux presentant une tolerance amelioree au stress environnemental
CN101268193A (zh) 2005-09-15 2008-09-17 克罗普迪塞恩股份有限公司 通过组3 lea表达的植物产量改良
EP2980220A1 (fr) 2005-09-20 2016-02-03 BASF Plant Science GmbH Procédés améliorés de contrôle de l'expression de gènes
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
DE102005052551A1 (de) 2005-11-02 2007-05-16 Rothamsted Res Harpenden Verfahren zur Herstellung von y-Linolensäure und/oder Stearidonsäure in transgenen Brassicaceae und Linaceae
AU2006311089C1 (en) 2005-11-08 2012-11-08 Basf Plant Science Gmbh Use of armadillo repeat (ARM1) polynucleotides for obtaining pathogen resistance in plants
US7723574B2 (en) 2005-11-24 2010-05-25 Basf Plant Science Gmbh Process for the production of Δ5-unsaturated fatty acids in transgenic organisms
WO2007080143A1 (fr) 2006-01-12 2007-07-19 Basf Plant Science Gmbh Utilisation de polynucléotides de la stomatine (stm1) pour obtenir une résistance à un pathogène dans des végétaux
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
US20090172834A1 (en) 2006-03-24 2009-07-02 Basf Plant Science Gmbh Proteins Associated With Abiotic Stress Response And Homologs
EP2441844A1 (fr) 2006-03-31 2012-04-18 BASF Plant Science GmbH Installations dotées de caractéristiques de rendement améliorées et procédé de fabrication de celles-ci
CA2644273A1 (fr) 2006-04-05 2008-03-27 Metanomics Gmbh Procede de production d'un produit chimique fin
EP2497778A3 (fr) 2006-05-31 2012-12-12 Metanomics GmbH Manipulation du métabolisme d'azote
CA2649341A1 (fr) 2006-06-08 2007-12-13 Basf Plant Science Gmbh Vegetaux aux caracteristiques de croissance ameliorees et procede d'obtention
EP2199396A1 (fr) 2006-08-02 2010-06-23 CropDesign N.V. Plantes transformées avec un polypeptide-syt qui sous un stress abiotique presentent un rendement amelioré, et leur procédé de production
EP2061879A2 (fr) 2006-08-24 2009-05-27 BASF Plant Science GmbH Isolation et caractérisation d'une nouvelle omega-3 désaturase de pythium ayant une spécificité vis-à-vis de tous les acides gras omega-6 ayant une chaîne plus longue que 18 atomes de carbone
US8222486B2 (en) 2006-08-30 2012-07-17 Basf Plant Science Gmbh Method for increasing resistance to pathogens in transgenic plants
WO2008040787A2 (fr) 2006-10-06 2008-04-10 Basf Plant Science Gmbh Procédé de production d'acides gras polyinsaturés dans des organismes transgéniques
US8329988B2 (en) 2006-10-12 2012-12-11 Basf Plant Science Gmbh Method for increasing pathogen resistance in transgenic plants
WO2008043849A2 (fr) 2006-10-13 2008-04-17 Basf Plant Science Gmbh Plantes présentant un rendement accru
EP2202314B1 (fr) 2007-01-15 2014-03-12 BASF Plant Science GmbH Utilisation de polynucléotides de la subtilisine (RNR9) pour obtenir une résistance à un pathogène dans les plantes
BRPI0811531A2 (pt) 2007-05-04 2014-10-07 Basf Plant Science Gmbh Polinucleotídeo, vetor, metódo para a fabricação de um polipeptídeo de piruvato quinase, polipeptídeo de piruvato quinase montado, anticorpo, célula hospedeira, organismo transgênico não humano, semente, métodos para a fabricação de um composto de armazenagem de semente e para a fabricação de uma planta, uso do organismo não humano transgênico ou da semente, e, molécula de ácido nucleico.
DE112008001452T5 (de) 2007-05-22 2010-12-16 Basf Plant Science Gmbh Pflanzen mit erhöhter Toleranz und/oder Resistenz gegen Umweltstress und erhöhter Biomasseproduktion
EP2074220A2 (fr) 2007-05-22 2009-07-01 BASF Plant Science GmbH Cellules vegetales et plantes presentant une tolérance et/ou une resistance accrues au stress environnemental et une production-ko de biomasse accrue
CN101861393B (zh) 2007-09-18 2013-12-25 巴斯夫植物科学有限公司 产量提高的植物
DE112008002456T5 (de) 2007-09-21 2011-01-13 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag
WO2009077611A2 (fr) 2007-12-19 2009-06-25 Basf Plant Science Gmbh Plantes avec rendement accru et/ou tolérance accrue à un stress environnemental (iy-bm)
DE112008003433T5 (de) 2007-12-21 2010-11-04 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag (KO NUE)
AR070719A1 (es) 2008-02-27 2010-04-28 Basf Plant Science Gmbh Plantas con mayor rendimiento, en terminos de crecimiento, desarrollo, acumulacion de biomasas y generacion de semillas en comparacion con una planta silvestre, y un metodo para producirlas.
DE112009001385T5 (de) 2008-06-03 2011-04-14 Basf Plant Science Gmbh Fettsäure-Dehydratasen und Anwendungen davon
US20110154530A1 (en) 2008-08-19 2011-06-23 Basf Plant Science Gmbh Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof
EP2331695B1 (fr) 2008-08-26 2014-07-23 BASF Plant Science GmbH Acides nucléiques codant des désaturases et huile végétale modifiée
CA2736473A1 (fr) 2008-09-23 2010-04-01 Basf Plant Science Gmbh Vegetaux a rendement accru (lt)
EP2350287A2 (fr) 2008-10-23 2011-08-03 BASF Plant Science GmbH Procédé pour produire une cellule transgénique avec une teneur en acide gamma-aminobutyrique (gaba) augmentée
DE112009002577T5 (de) 2008-10-23 2012-06-21 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag (NUE)
EP2376638B1 (fr) 2008-12-12 2013-08-14 BASF Plant Science GmbH Désaturases et procédé pour la production d'acides gras polyinsaturés dans des organismes transgéniques
EP2199399A1 (fr) 2008-12-17 2010-06-23 BASF Plant Science GmbH Production de cétocaroténoïdes dans les plantes
WO2010130725A1 (fr) 2009-05-13 2010-11-18 Basf Plant Science Company Gmbh Acyltransférases et leurs utilisations dans la production d'acide gras
CN102597242B (zh) 2009-06-08 2016-03-02 罗特哈姆斯泰德研究有限公司 新脂肪酸延伸组合物及其用途
WO2011006948A1 (fr) 2009-07-17 2011-01-20 Basf Plant Science Company Gmbh Nouvelles désaturases et élongases d'acide gras et leurs utilisations
AU2010275363A1 (en) 2009-07-23 2012-02-02 Basf Plant Science Company Gmbh Plants with increased yield
EP3178937B1 (fr) 2009-08-31 2018-11-07 BASF Plant Science Company GmbH Molécules d'acide nucléique régulatrices pour l'amélioration de l'expression de gènes spécifiques des semences dans des plantes pour faciliter la synthèse améliorée d'acides gras polyinsaturés
WO2011061656A1 (fr) 2009-11-17 2011-05-26 Basf Plant Science Company Gmbh Plantes à rendement accru
WO2011064181A1 (fr) 2009-11-24 2011-06-03 Basf Plant Science Company Gmbh Nouvelle désaturase d'acides gras et ses utilisations
US9347049B2 (en) 2009-11-24 2016-05-24 Basf Plant Science Company Gmbh Fatty acid elongase and uses thereof
US9388437B2 (en) 2010-06-25 2016-07-12 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
US9458477B2 (en) 2010-10-21 2016-10-04 Basf Plant Science Company Gmbh Fatty acid desaturases, elongases, elongation components and uses thereof
EP2612918A1 (fr) 2012-01-06 2013-07-10 BASF Plant Science Company GmbH Recombinaison in planta
WO2014020533A2 (fr) 2012-08-03 2014-02-06 Basf Plant Science Company Gmbh Nouvelles enzymes, composants enzymatiques et leurs utilisations
WO2015092709A1 (fr) 2013-12-17 2015-06-25 Basf Plant Science Company Gmbh Procédés de conversion de la spécificité de substrat de désaturases
JP7423177B2 (ja) 2014-11-14 2024-01-29 ビーエーエスエフ プラント サイエンス カンパニー ゲーエムベーハー Ｐｕｆａを含有する植物性脂質の改質
WO2016128470A1 (fr) 2015-02-11 2016-08-18 Basf Se Hydroxyphénylpyruvate dioxygénases résistantes aux herbicides
EP3354738A1 (fr) 2017-01-30 2018-08-01 Kws Saat Se Plantes de maïs transgéniques présentant un rendement accru et une meilleure tolérance à la sécheresse
CA3129494A1 (fr) 2019-02-14 2020-08-20 Cargill, Incorporated Plantes brassica produisant des taux eleves d'acides gras polyinsatures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
JPS592689A (ja) 1982-06-04 1984-01-09 Handai Biseibutsubiyou Kenkyukai 強力な遺伝子発現能を有する新規レプリコンの作成法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8909267A2 *

Also Published As

Publication number Publication date
WO1989009267A3 (fr) 1989-11-16
WO1989009267A2 (fr) 1989-10-05
IL89606A0 (en) 1989-09-10
DK232690A (da) 1990-11-23
AU626012B2 (en) 1992-07-23
EP0335528A2 (fr) 1989-11-15
AU3356389A (en) 1989-10-16
NZ228320A (en) 1991-06-25
JPH03504318A (ja) 1991-09-26
DK232690D0 (da) 1990-09-26
EP0335528A3 (fr) 1989-11-15

Similar Documents

Publication Publication Date Title
AU626012B2 (en) Dna promoter fragments from wheat
Abel et al. Transient transformation of Arabidopsis leaf protoplasts: a versatile experimental system to study gene expression
Kim et al. Identification of methyl jasmonate and salicylic acid response elements from the nopaline synthase (nos) promoter
KR100228918B1 (ko) 헬리안티닌의 상부 조절요소를 기초로 한 키메릭 식물 유전자
KR0154872B1 (ko) 발아하는 식물종자의 아크로박테리움 매개된 형질전환
EP0637339B1 (fr) Constructions d'adn et plantes les incorporant
EP0459643B1 (fr) Promoteur recombinant pour l'expression de gènes dans des monocotylédones
Elliott et al. Cis-acting elements for light regulation of pea ferredoxin I gene expression are located within transcribed sequences.
US5712112A (en) Gene expression system comprising the promoter region of the alpha-amylase genes
Anuradha et al. Genetic transformation of peanut (Arachis hypogaea L.) using cotyledonary node as explant and a promoterless gus:: npt II fusion gene based vector
CA2007091A1 (fr) Regulation transcriptionnelle specifique de tubercules de pommes de terre
US5460952A (en) Gene expression system comprising the promoter region of the α-amylase genes
JPH0279983A (ja) 植物のユビキチンプロモーター系
EP0602113B1 (fr) Promoteurs specifiques de certains cals vegetaux
HU220358B (hu) Eljárás hibrid vetőmagok előállítására
US5866793A (en) Promoter for expressing foreign genes in monocotyledonous plants
CA2146712C (fr) Promoteur a induction par le froid, provenant de brassicus napus d'hiver
US5139954A (en) DNA promoter fragments from wheat
US7557264B2 (en) Gossypium hirsutum tissue-specific promoters and their use
Hotter et al. Cis elements and potential trans-acting factors for the developmental regulation of the Phaseolus vulgaris CHS15 promoter
US5824865A (en) Chimeric plant genes based on upstream regulatory elements of helianthinin
JPS60210988A (ja) 植物構造遺伝子の発現
RU2237717C2 (ru) Рекомбинантная плазмида pgbp450f для получения трансгенных растений и способ получения трансгенных растений табака с повышенной продуктивностью и устойчивостью к грибным фитопатогенам
Rooke Studies on position effects and gene tagging in transgenic plants
JPH0589A (ja) 遺伝子発現の誘導方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900921

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920403

XX Miscellaneous (additional remarks)

Free format text: VERBUNDEN MIT 89302566.8/0335528 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 24.07.92.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19940503